Ayala Pharmaceuticals Inc (OTCPK:ADXS)
$ 0.027 0 (0%) Market Cap: 1.15 Mil Enterprise Value: 4.58 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q2 2019 Advaxis Inc Earnings Call Transcript

Jun 11, 2019 / 03:00PM GMT
Operator

Good morning, and welcome to the Advaxis, Inc. Business Update Call. (Operator Instructions) As a reminder, this conference is being recorded, June 11, 2019. I would now like to turn the conference over to Yvonne Briggs from LHA. Please go ahead.

Yvonne Briggs
LHA Investor Relations - VP

Good morning. This is Yvonne Briggs from -- with LHA, the Investor Relations agency for Advaxis. Thank you all for participating on today's call. Joining me from Advaxis are Ken Berlin, President and Chief Executive Officer; Dr. Andres Gutierrez, Chief Medical Officer; and Molly Henderson, Chief Financial Officer.

Yesterday, after market close, Advaxis issued a press release reporting fiscal second quarter financial results and highlights of the company's clinical pipeline. If you've not received this news release or if you'd like to be added to the company's e-mail distribution list, please call LHA at (212) 838-3777 and speak with Carolyn Curran.

Before we begin, I'd like to remind you that comments made by management during this call will contain forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot